Sign in
4

Changes in Ownership

Kairos Pharma, LTD. Filed Acc 0001493152-25-029601

Chief Scientific Officer acquired 171,756 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bhowmick Neil Chief Scientific Officer 2025-10-08 Grant or award +171,756 1,311,739 D
Loading xslF345X05/ownership.xml…